1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Itching in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Gomułka, K; Mędrala, W | 1 |
Ferrán, M; Giménez-Arnau, A; Izquierdo, I; Maurer, M; Metz, M; Scholz, E | 1 |
Church, MK | 1 |
Kato, M; Kurose, T; Miyaji, S; Oda, T | 1 |
Iinuma, M; Ishiguro, K; Oku, H; Ueda, Y | 1 |
Cunningham, FM; Foster, AP; Lees, P | 1 |
Nieves, AL; Spada, CS; Tuckett, RP; Williams, LS; Woodward, DF | 1 |
Fjellner, B; Hägermark, O | 1 |
2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Itching
Article | Year |
---|---|
Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria.
Topics: Adult; Cold Temperature; Cyproheptadine; Double-Blind Method; Environmental Exposure; Female; Histamine Antagonists; Humans; Male; Middle Aged; Platelet Activating Factor; Pruritus; Treatment Outcome; Urticaria | 2010 |
Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin.
Topics: Adult; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Female; Histamine; Humans; Male; Middle Aged; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Pruritus; Pyrilamine; Skin | 1985 |
6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Itching
Article | Year |
---|---|
Serum Levels of Vascular Endothelial Growth Factor, Platelet Activating Factor and Eosinophil-Derived Neurotoxin in Chronic Spontaneous Urticaria-A Pilot Study in Adult Patients.
Topics: Adult; Chronic Disease; Chronic Urticaria; Cytokines; Eosinophil-Derived Neurotoxin; Humans; Pilot Projects; Platelet Activating Factor; Pruritus; Urticaria; Vascular Endothelial Growth Factor A | 2022 |
Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males.
Topics: Administration, Oral; Adult; Area Under Curve; Cyproheptadine; Histamine; Histamine H1 Antagonists; Humans; Injections, Intradermal; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pruritus; Skin; Young Adult | 2010 |
The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis.
Topics: Animals; Antigens; Azepines; Capillary Permeability; Conjunctivitis, Allergic; Disease Models, Animal; Dose-Response Relationship, Drug; Dye Dilution Technique; Guinea Pigs; Humans; Immunization, Passive; Ketotifen; Male; Ophthalmic Solutions; Platelet Activating Factor; Pruritus; Time Factors; Triazoles | 2003 |
Antianaphylactic and antipruritic effects of the flowers of Impatiens textori MIQ.
Topics: Anaphylaxis; Animals; Behavior, Animal; Blood Pressure; Flowers; Hypnotics and Sedatives; Immunoglobulin E; Impatiens; Male; Mice; Motor Activity; Muramidase; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Pruritus; Regional Blood Flow; Serotonin | 2005 |
Platelet activating factor mimics antigen-induced cutaneous inflammatory responses in sweet itch horses.
Topics: Animals; Capillary Permeability; Ceratopogonidae; Chemotaxis, Leukocyte; Dermatitis, Allergic Contact; Female; Horse Diseases; Horses; Male; Platelet Activating Factor; Pruritus | 1995 |
Characterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen.
Topics: Animals; Azepines; Female; Guinea Pigs; Histamine; Male; Platelet Activating Factor; Pruritus; Pyridinium Compounds; Triazoles | 1995 |